Showing results (2101-2110 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|June 25, 2016
The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignanciesThomas M Baker, Michael J Satlin
Leukemia & Lymphoma|February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
Leukemia & Lymphoma|February 20, 2016
Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challengesLaura Moench, Zohar Sachs, Garth Aasen, et al.
Leukemia & Lymphoma|February 27, 2016
Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myelomaFlora Zagouri, Maria Roussou, Efstathios Kastritis, et al.
Leukemia & Lymphoma|February 27, 2016
Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemiaChihiro Yamamoto, Shoko Ito, Kiyomi Mashima, et al.
Leukemia & Lymphoma|February 17, 2016
Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantationPu Kuang, Ting Liu, Ling Pan, et al.
Leukemia & Lymphoma|February 17, 2016
Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR)Wolfgang Willenbacher, Shanmugapriya Thangavadivel, Richard Greil, et al.
Leukemia & Lymphoma|February 19, 2016
Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, ChinaJin Lu, Jian Hou, Kai-Yan Liu, et al.
Leukemia & Lymphoma|December 17, 2014
Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemiaSanne H Tonino, Chantal E Mulkens, Jacoline van Laar, et al.
Leukemia & Lymphoma|August 4, 2015
Temsirolimus inhibits cell growth in combination with inhibitors of the B-cell receptor pathwayAnna-Katharina Zoellner, Stephan Bayerl, Grit Hutter, et al.
Pageof 1,001